ROCKVILLE, Md., Jan. 30, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced data from its RGX-121 (clemidsogene lanparvovec) program for the treatment of mucopolysaccharidosis type ...

Along with the hybrid tech, the Yamaha FZ-S Fi Hybrid comes with additional features like single-channel ABS and traction control for added safety. It weighs 300 lb (136 kg) and has a 3.4-gal (13 ...

The company is trading for roughly the cash on its balance sheet. The RGX-121 program is presently the furthest in development. REGENXBIO is pushing ahead with partner Nippon Shinyaku to ...

With respect to this article, I noted that the company had obtained additional positive data from its Phase 1/2/3 CAMPSIITE study using RGX-121 for the treatment of these patients with MPS II.

Last year, he broke out with 1,212 receiving yards, 86 receptions, and nine touchdowns. Pairing him with Lamb could give the Cowboys exactly what they need to jumpstart the offense without ...

(RTTNews) - REGENXBIO Inc. (RGNX) and Nippon Shinyaku announced a strategic partnership for the development and commercialization of RGX-121 for the treatment of Mucopolysaccharidosis II ...